Pharma & Healthcare

Global Anti-allergic Drugs Market Research Report 2024

The global Anti-allergic Drugs market was valued at US$ 10980 million in 2023 and is anticipated to reach US$ 14400 million by 2030, witnessing a CAGR of 3.9% during the forecast period 2024-2030.
Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.
This report aims to provide a comprehensive presentation of the global market for Anti-allergic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-allergic Drugs.
Report Scope
The Anti-allergic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-allergic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Sales Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-allergic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channel, and by regions.
Market Segmentation
By Company
Sanofi
Johnson And Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays
Segment by Type
Oral Drugs
Non-Oral Drugs
Segment by Sales Channel
Online
Offline
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Sales Channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-allergic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-allergic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Drugs
1.2.3 Non-Oral Drugs
1.3 Market by Sales Channel
1.3.1 Global Anti-allergic Drugs Market Growth by Sales Channel: 2019 VS 2023 VS 2030
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-allergic Drugs Market Perspective (2019-2030)
2.2 Anti-allergic Drugs Growth Trends by Region
2.2.1 Global Anti-allergic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-allergic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Anti-allergic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Anti-allergic Drugs Market Dynamics
2.3.1 Anti-allergic Drugs Industry Trends
2.3.2 Anti-allergic Drugs Market Drivers
2.3.3 Anti-allergic Drugs Market Challenges
2.3.4 Anti-allergic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-allergic Drugs Players by Revenue
3.1.1 Global Top Anti-allergic Drugs Players by Revenue (2019-2024)
3.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-allergic Drugs Revenue
3.4 Global Anti-allergic Drugs Market Concentration Ratio
3.4.1 Global Anti-allergic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-allergic Drugs Revenue in 2023
3.5 Anti-allergic Drugs Key Players Head office and Area Served
3.6 Key Players Anti-allergic Drugs Product Solution and Service
3.7 Date of Enter into Anti-allergic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-allergic Drugs Breakdown Data by Type
4.1 Global Anti-allergic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Anti-allergic Drugs Forecasted Market Size by Type (2025-2030)
5 Anti-allergic Drugs Breakdown Data by Sales Channel
5.1 Global Anti-allergic Drugs Historic Market Size by Sales Channel (2019-2024)
5.2 Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2025-2030)
6 North America
6.1 North America Anti-allergic Drugs Market Size (2019-2030)
6.2 North America Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-allergic Drugs Market Size by Country (2019-2024)
6.4 North America Anti-allergic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-allergic Drugs Market Size (2019-2030)
7.2 Europe Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-allergic Drugs Market Size by Country (2019-2024)
7.4 Europe Anti-allergic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-allergic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Anti-allergic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-allergic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-allergic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-allergic Drugs Market Size (2019-2030)
9.2 Latin America Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-allergic Drugs Market Size by Country (2019-2024)
9.4 Latin America Anti-allergic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-allergic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Anti-allergic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-allergic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-allergic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anti-allergic Drugs Introduction
11.1.4 Sanofi Revenue in Anti-allergic Drugs Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Johnson And Johnson
11.2.1 Johnson And Johnson Company Detail
11.2.2 Johnson And Johnson Business Overview
11.2.3 Johnson And Johnson Anti-allergic Drugs Introduction
11.2.4 Johnson And Johnson Revenue in Anti-allergic Drugs Business (2019-2024)
11.2.5 Johnson And Johnson Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Anti-allergic Drugs Introduction
11.3.4 Merck Revenue in Anti-allergic Drugs Business (2019-2024)
11.3.5 Merck Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva Anti-allergic Drugs Introduction
11.4.4 Teva Revenue in Anti-allergic Drugs Business (2019-2024)
11.4.5 Teva Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Anti-allergic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Bayer
11.6.1 Bayer Company Detail
11.6.2 Bayer Business Overview
11.6.3 Bayer Anti-allergic Drugs Introduction
11.6.4 Bayer Revenue in Anti-allergic Drugs Business (2019-2024)
11.6.5 Bayer Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Detail
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Anti-allergic Drugs Introduction
11.7.4 Sun Pharma Revenue in Anti-allergic Drugs Business (2019-2024)
11.7.5 Sun Pharma Recent Development
11.8 UCB Pharma
11.8.1 UCB Pharma Company Detail
11.8.2 UCB Pharma Business Overview
11.8.3 UCB Pharma Anti-allergic Drugs Introduction
11.8.4 UCB Pharma Revenue in Anti-allergic Drugs Business (2019-2024)
11.8.5 UCB Pharma Recent Development
11.9 Yangtze River Pharmaceutical Group
11.9.1 Yangtze River Pharmaceutical Group Company Detail
11.9.2 Yangtze River Pharmaceutical Group Business Overview
11.9.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Introduction
11.9.4 Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2019-2024)
11.9.5 Yangtze River Pharmaceutical Group Recent Development
11.10 Hainan Poly Pharm
11.10.1 Hainan Poly Pharm Company Detail
11.10.2 Hainan Poly Pharm Business Overview
11.10.3 Hainan Poly Pharm Anti-allergic Drugs Introduction
11.10.4 Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2019-2024)
11.10.5 Hainan Poly Pharm Recent Development
11.11 Chongqing Huapont Pharmaceutical
11.11.1 Chongqing Huapont Pharmaceutical Company Detail
11.11.2 Chongqing Huapont Pharmaceutical Business Overview
11.11.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Introduction
11.11.4 Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2019-2024)
11.11.5 Chongqing Huapont Pharmaceutical Recent Development
11.12 Dawnrays
11.12.1 Dawnrays Company Detail
11.12.2 Dawnrays Business Overview
11.12.3 Dawnrays Anti-allergic Drugs Introduction
11.12.4 Dawnrays Revenue in Anti-allergic Drugs Business (2019-2024)
11.12.5 Dawnrays Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Drugs
Table 3. Key Players of Non-Oral Drugs
Table 4. Global Anti-allergic Drugs Market Size Growth by Sales Channel (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Anti-allergic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Anti-allergic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Anti-allergic Drugs Market Share by Region (2019-2024)
Table 8. Global Anti-allergic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Anti-allergic Drugs Market Share by Region (2025-2030)
Table 10. Anti-allergic Drugs Market Trends
Table 11. Anti-allergic Drugs Market Drivers
Table 12. Anti-allergic Drugs Market Challenges
Table 13. Anti-allergic Drugs Market Restraints
Table 14. Global Anti-allergic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Anti-allergic Drugs Market Share by Players (2019-2024)
Table 16. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2023)
Table 17. Ranking of Global Top Anti-allergic Drugs Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Anti-allergic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-allergic Drugs Product Solution and Service
Table 21. Date of Enter into Anti-allergic Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-allergic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Anti-allergic Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Anti-allergic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Anti-allergic Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Anti-allergic Drugs Market Size by Sales Channel (2019-2024) & (US$ Million)
Table 28. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2019-2024)
Table 29. Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2025-2030) & (US$ Million)
Table 30. Global Anti-allergic Drugs Revenue Market Share by Sales Channel (2025-2030)
Table 31. North America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Anti-allergic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Anti-allergic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Anti-allergic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Anti-allergic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Anti-allergic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Anti-allergic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Anti-allergic Drugs Product
Table 49. Sanofi Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Johnson And Johnson Company Detail
Table 52. Johnson And Johnson Business Overview
Table 53. Johnson And Johnson Anti-allergic Drugs Product
Table 54. Johnson And Johnson Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 55. Johnson And Johnson Recent Development
Table 56. Merck Company Detail
Table 57. Merck Business Overview
Table 58. Merck Anti-allergic Drugs Product
Table 59. Merck Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 60. Merck Recent Development
Table 61. Teva Company Detail
Table 62. Teva Business Overview
Table 63. Teva Anti-allergic Drugs Product
Table 64. Teva Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 65. Teva Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Anti-allergic Drugs Product
Table 69. GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Bayer Company Detail
Table 72. Bayer Business Overview
Table 73. Bayer Anti-allergic Drugs Product
Table 74. Bayer Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Sun Pharma Company Detail
Table 77. Sun Pharma Business Overview
Table 78. Sun Pharma Anti-allergic Drugs Product
Table 79. Sun Pharma Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 80. Sun Pharma Recent Development
Table 81. UCB Pharma Company Detail
Table 82. UCB Pharma Business Overview
Table 83. UCB Pharma Anti-allergic Drugs Product
Table 84. UCB Pharma Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 85. UCB Pharma Recent Development
Table 86. Yangtze River Pharmaceutical Group Company Detail
Table 87. Yangtze River Pharmaceutical Group Business Overview
Table 88. Yangtze River Pharmaceutical Group Anti-allergic Drugs Product
Table 89. Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 90. Yangtze River Pharmaceutical Group Recent Development
Table 91. Hainan Poly Pharm Company Detail
Table 92. Hainan Poly Pharm Business Overview
Table 93. Hainan Poly Pharm Anti-allergic Drugs Product
Table 94. Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 95. Hainan Poly Pharm Recent Development
Table 96. Chongqing Huapont Pharmaceutical Company Detail
Table 97. Chongqing Huapont Pharmaceutical Business Overview
Table 98. Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product
Table 99. Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 100. Chongqing Huapont Pharmaceutical Recent Development
Table 101. Dawnrays Company Detail
Table 102. Dawnrays Business Overview
Table 103. Dawnrays Anti-allergic Drugs Product
Table 104. Dawnrays Revenue in Anti-allergic Drugs Business (2019-2024) & (US$ Million)
Table 105. Dawnrays Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-allergic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Anti-allergic Drugs Market Share by Type: 2023 VS 2030
Figure 3. Oral Drugs Features
Figure 4. Non-Oral Drugs Features
Figure 5. Global Anti-allergic Drugs Market Size Comparison by Sales Channel (2024-2030) & (US$ Million)
Figure 6. Global Anti-allergic Drugs Market Share by Sales Channel: 2023 VS 2030
Figure 7. Online Case Studies
Figure 8. Offline Case Studies
Figure 9. Anti-allergic Drugs Report Years Considered
Figure 10. Global Anti-allergic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Anti-allergic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Anti-allergic Drugs Market Share by Region: 2023 VS 2030
Figure 13. Global Anti-allergic Drugs Market Share by Players in 2023
Figure 14. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Anti-allergic Drugs Revenue in 2023
Figure 16. North America Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Anti-allergic Drugs Market Share by Country (2019-2030)
Figure 18. United States Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Anti-allergic Drugs Market Share by Country (2019-2030)
Figure 22. Germany Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Anti-allergic Drugs Market Share by Region (2019-2030)
Figure 30. China Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Anti-allergic Drugs Market Share by Country (2019-2030)
Figure 38. Mexico Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Anti-allergic Drugs Market Share by Country (2019-2030)
Figure 42. Turkey Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Anti-allergic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Sanofi Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 45. Johnson And Johnson Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 46. Merck Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 47. Teva Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 48. GlaxoSmithKline Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 49. Bayer Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 50. Sun Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 51. UCB Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 52. Yangtze River Pharmaceutical Group Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 53. Hainan Poly Pharm Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 54. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 55. Dawnrays Revenue Growth Rate in Anti-allergic Drugs Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies